New Drug Hope for Blood Cancer Patients
Game-Changer Drug Now Available
Hundreds of blood cancer patients will soon have access to a new drug that could be a game-changer in their treatment. The drug, known as CAR-T therapy, is a type of immunotherapy that uses the patient's own immune cells to fight cancer. CAR-T therapy has been shown to be very effective in treating certain types of blood cancer, including diffuse large B-cell lymphoma (DLBCL).
How CAR-T Therapy Works
CAR-T therapy involves taking immune cells from the patient's blood and genetically modifying them to express a chimeric antigen receptor (CAR). This CAR is designed to bind to a specific protein on the surface of cancer cells. Once the CAR-T cells are infused back into the patient, they can recognize and attack the cancer cells.
Promising Results
CAR-T therapy has shown promising results in clinical trials. In one study, 83% of patients with DLBCL who received CAR-T therapy had a complete response, meaning that their cancer disappeared completely. The median progression-free survival was 28 months, which is significantly longer than the median progression-free survival of patients who received standard treatment.
Conclusion
CAR-T therapy is a promising new treatment for blood cancer patients. The drug has been shown to be very effective in clinical trials, and it is now available to hundreds of patients through the NHS. CAR-T therapy is a major step forward in the fight against blood cancer, and it could provide new hope for patients who have not responded to other treatments.
Yahoo News Uk
Https Www Independentnurse Co Uk Content News First Targeted Treatment Could Be A Game Changer For Hundreds Of Blood Cancer Patients
تعليقات